APA (7th ed.) Citation

MM, F., AA, M., M, A., EM, A., ST, A., & HA, A. (2023). New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study. Molecules (Basel, Switzerland), 28(21), . https://doi.org/10.3390/molecules28217455

Chicago Style (17th ed.) Citation

MM, Fakhry, Mattar AA, Alsulaimany M, Al-Olayan EM, Al-Rashood ST, and Abdel-Aziz HA. "New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study." Molecules (Basel, Switzerland) 28, no. 21 (2023). https://doi.org/10.3390/molecules28217455.

MLA (9th ed.) Citation

MM, Fakhry, et al. "New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study." Molecules (Basel, Switzerland), vol. 28, no. 21, 2023, https://doi.org/10.3390/molecules28217455.